Press Releases

Click Here to Watch: Strategies to Effectively Discuss Childhood Vaccines WebinarThe North Carolina Department of Health and Human Services (NCDHHS) is excited to announce the release of our new educational webinar, housed within our Childhood Vaccine Toolkit.
Dear Local Health Department Partner,
This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.  
This email is to inform you of the final dates to submit orders for the 2024–2025 COVID-19 vaccine season. Based on vaccine shelf life and product availability, the last ordering dates are as follows: 
Dear Local Health Department Partner,This email is to inform you that the North Carolina Immunization Program (NCIP) has additional 317 VFA funding to support MMR vaccine availability for Local Health Departments (LHDs). This supplemental funding expires at the end of September, or until funds are exhausted.  MMR is routinely available to LHDs for uninsured eligible adults through the NCIP with 317 VFA funds. However, this additional, time-limited funding allows for an increased supply of MMR doses to support your vaccination efforts.
The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.  
Download the RSV Vaccine Available for Ordering MemoThe purpose of this memo is to provide VFC- enrolled providers with information on ordering timelines and administration start dates for the maternal RSV vaccine (ABRYSVO®) and the monoclonal antibody nirsevimab (Beyfortus®) for the upcoming season.
We are writing to inform you of several changes to the Vaccines for Children (VFC) program policies that may affect your practice, effective July 1, 2025. These updates pertain to the COVID-19 vaccine recommendations, RSV monoclonal antibody products, private stock vaccine requirements and the definition of underinsured. Please review the information below and reach out with any questions.COVID-19 Vaccine Stock
This email is to inform you of an important update to share regarding measles reporting, testing, and vaccination.
In This IssueMessage from the ChairmanCertification Renewal Season is Here2025 JubileeModern Well Drilling Industry TechnologyOnline GW-1 SubmissionSWIFT TeamOnline FormsCommissioner SwicegoodPump TagsCommission Members and StaffCertification Today